Hitesh B Mistry (Hitesh Mistry)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Venues

Clinical pharmacology and therapeutics

British journal of cancer

Cancers

CPT: pharmacometrics & systems pharmacology

University of Manchester (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Manchester Sep 20 2003 - Dec 01 2006

United Kingdom

PHD :: Mathematics

University of Manchester Sep 20 2002 - Aug 31 2003

United Kingdom

MSC :: Mathematics

UMIST Sep 20 1999 - Jul 01 2002

United Kingdom

BSC :: Mathematics

Publications

Zhonghui Huang, Paolo Denti, Hitesh B Mistry, Frank Kloprogge
Machine Learning and Artificial Intelligence in PK-PD Modeling: Fad, Friend, or Foe? Clinical pharmacology and therapeutics 115 (4) (2024)
Zhonghui Huang, Paolo Denti, Hitesh B Mistry, Frank Kloprogge
Machine Learning and Artificial Intelligence in PK-PD Modeling: Fad, Friend, or Foe? Clinical pharmacology and therapeutics 115 (4) (2024)
Zhonghui Huang, Paolo Denti, Hitesh B Mistry, Frank Kloprogge
Machine Learning and Artificial Intelligence in PK-PD Modeling: Fad, Friend, or Foe? Clinical pharmacology and therapeutics (2024)
Kavi Fatania, Russell Frood, Hitesh B Mistry, Susan C Short, James O'Connor, Andrew F Scarsbrook, Stuart Currie
Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling Study. Cancers 16 (7) (2024)
Kavi Fatania, Russell Frood, Hitesh B Mistry, Susan C Short, James O'Connor, Andrew F Scarsbrook, Stuart Currie
Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling Study. Cancers 16 (7) (2024)
Zhonghui Huang, Paolo Denti, Hitesh B Mistry, Frank Kloprogge
Machine Learning and Artificial Intelligence in PK-PD Modeling: Fad, Friend, or Foe? Clinical pharmacology and therapeutics 115 (4) (2024)
Kavi Fatania, Russell Frood, Hitesh B Mistry, Susan C Short, James O'Connor, Andrew F Scarsbrook, Stuart Currie
Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling Study. Cancers 16 (7) (2024)
Zhonghui Huang, Paolo Denti, Hitesh B Mistry, Frank Kloprogge
Machine Learning and Artificial Intelligence in PK-PD Modeling: Fad, Friend, or Foe? Clinical pharmacology and therapeutics 115 (4) (2024)
Zhonghui Huang, Paolo Denti, Hitesh B Mistry, Frank Kloprogge
Machine Learning and Artificial Intelligence in PK-PD Modeling: Fad, Friend, or Foe? Clinical pharmacology and therapeutics 115 (4) (2024)
Laura J Forker, Becky Bibby, Lingjian Yang, Brian Lane, Joely Irlam, Hitesh B Mistry, Mairah Khan, Helen Valentine, James Wylie, Patrick Shenjere, Michael Leahy, Piers Gaunt, Lucinda Billingham, Beatrice M Seddon, Rob Grimer, Martin Robinson, Ananya Choudhury, Catharine M L West
Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma. British journal of cancer (2023)
Laura J Forker, Becky Bibby, Lingjian Yang, Brian Lane, Joely Irlam, Hitesh B Mistry, Mairah Khan, Helen Valentine, James Wylie, Patrick Shenjere, Michael Leahy, Piers Gaunt, Lucinda Billingham, Beatrice M Seddon, Rob Grimer, Martin Robinson, Ananya Choudhury, Catharine M L West
Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma. British journal of cancer (2023)
Laura J Forker, Becky Bibby, Lingjian Yang, Brian Lane, Joely Irlam, Hitesh B Mistry, Mairah Khan, Helen Valentine, James Wylie, Patrick Shenjere, Michael Leahy, Piers Gaunt, Lucinda Billingham, Beatrice M Seddon, Rob Grimer, Martin Robinson, Ananya Choudhury, Catharine M L West
Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma. British journal of cancer (2023)
Laura J Forker, Becky Bibby, Lingjian Yang, Brian Lane, Joely Irlam, Hitesh B Mistry, Mairah Khan, Helen Valentine, James Wylie, Patrick Shenjere, Michael Leahy, Piers Gaunt, Lucinda Billingham, Beatrice M Seddon, Rob Grimer, Martin Robinson, Ananya Choudhury, Catharine M L West
Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma. British journal of cancer (2023)
James W T Yates, Hitesh B Mistry
Skipping a pillar does not make for strong foundations: Pharmacokinetic-pharmacodynamic reasoning behind the shape of dose-response relationships in oncology. CPT: pharmacometrics & systems pharmacology (2023)
David Hodson, Hitesh B Mistry, Sofia Guzzetti, Michael Davies, Anna Staniszewska, Paul Farrington, Elaine Cadogan, James Yates, Leon Aarons, Kayode Ogungbenro
Mixed effects modeling of radiotherapy in combination with immune checkpoint blockade or inhibitors of the DNA damage response pathway. CPT: pharmacometrics & systems pharmacology (2023)
Martin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan, Katherine Murphy, Thiraviyam Elumalai, Manjusha Soni, Alexandra Ferrera, Charlotte Richardson, Richard Walshaw, Hitesh B Mistry, Vijay Ramani, Yeepei Song, Alison Jane Birtle, Ann Henry, Joachim Chan, Peter J Hoskin, Ananya Choudhury
Bladder-Sparing Treatment With Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients With Clinically Node-Positive Nonmetastatic Bladder Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hitesh B Mistry
On the reporting and analysis of a cancer evolutionary adaptive dosing trial. Nature communications 12 (1) (2021)
James W T Yates, Hitesh B Mistry
Clone Wars: Quantitatively Understanding Cancer Drug Resistance. JCO clinical cancer informatics 4 (2021)
Hitesh B Mistry, James W T Yates
Quantifying Preexisting Resistant and Persister Populations-Letter. Cancer research 79 (19) (2020)
Ahmed Salem, Ross A Little, Ayşe Latif, Adam K Featherstone, Muhammad Babur, Isabel Peset, Susan Cheung, Yvonne Watson, Victoria Tessyman, Hitesh B Mistry, Garry Ashton, Caron Behan, Julian C Matthews, Marie-Claude Asselin, Robert G Bristow, Alan Jackson, Geoffrey J M Parker, Corinne Faivre-Finn, Kaye J Williams, James P B O'Connor
Oxygen-enhanced MRI Is Feasible, Repeatable, and Detects Radiotherapy-induced Change in Hypoxia in Xenograft Models and in Patients with Non-small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (13) (2019)
Hitesh B Mistry, Gabriel Helmlinger, Nidal Al-Huniti, Karthick Vishwanathan, James Yates
Resistance models to EGFR inhibition and chemotherapy in non-small cell lung cancer via analysis of tumour size dynamics. Cancer chemotherapy and pharmacology 84 (1) (2019)
Hitesh B Mistry, David Orrell, Raluca Eftimie
Model based analysis of the heterogeneity in the tumour size dynamics differentiates vemurafenib, dabrafenib and trametinib in metastatic melanoma. Cancer chemotherapy and pharmacology 81 (2) (2017)

Hitesh B Mistry.css-eqlu8i{font-size:small;padding-left:4px;} (Hitesh Mistry)

Publication Activity (10 Years)

Top Topics

Top Venues

Hitesh B Mistry (Hitesh Mistry)